Spa Hype Puts Midjourney Body Scanner on Trial Before Proof

Midjourney body scanner is being pitched with MRI-level ambition and spa-level ease before Midjourney has shown the public evidence that medicine demands. That gap matters most for potential users, clinicians, and regulators, because a weird AI image is disposable. A misleading body scan is not.

The Verge reports that Midjourney, best known for its image generator, has announced a medical imaging pivot built around a water-based ultrasound scanner that would lower users into a vat and aim to produce “something as powerful as MRI” while feeling “as casual as a trip to the spa.”

That is a seductive pitch. It is also exactly the kind of language that should make health professionals tense up.

Midjourney body scanner users need proof before spa hype

The core problem is not that Midjourney is trying something strange. Strange ideas can become useful machines. The problem is that Midjourney Medical is talking in the emotional register of longevity, health optimization, and MRI-like insight while publicly offering far less than the evidence needed to support that weight.

The proposed system would place a person on a platform, lower them into water, and scan the body with a ring of underwater sensors that send sound waves through tissue and collect returning echoes. Midjourney says the scan goal is “to take no more than 60 seconds.” The company also says the broader aim is to help people live longer, better, and healthier lives.

Who carries the risk if a user walks away thinking that a wellness scan has meaning it does not actually have?

That question sits under every glossy render. Midjourney is not initially framing the scanner as a diagnostic medical device. It is positioning the first use around “detailed body composition maps” and spas, while saying it plans to expand into medical applications later. That choice lowers the immediate regulatory burden, but it also creates a trust problem: the marketing gestures toward medicine while the product lane starts in wellness.

“Every modality has its strengths and weaknesses. MRIs are powerful but expensive and slow. CT scanners are excellent for things like bone and lung imaging but expose patients to ionizing radiation. The first-generation scanner is fast, affordable, radiation-free, and great at imaging soft tissues like muscle and fat for body composition, but it won’t be a replacement for either of these technologies,” Midjourney’s Tom Calloway told The Verge.

That statement is more careful than the spa-MRI framing. Midjourney should lead with that caution, not bury it behind aspiration.

Builders cannot sell MRI-like insight like an AI art feature

Consumer tech launch culture rewards surprise. Medical device development rewards repeatability. That difference is everything.

MRI is not just a machine category. It is a benchmark built on engineering, clinical interpretation, workflow, safety protocols, and decades of use. If Midjourney wants to invoke MRI, it inherits a burden: show the images, show the error rates, show the comparison studies, and show how the system performs outside controlled demos.

The company’s public language has already invited expert pushback. Venkatesh Murthy, a professor of preventive cardiology, internal medicine, and radiology at the University of Michigan Medical School, told The Verge the technology is “super cool,” but warned there is “a long road ahead to generating high-quality images and then to understand the clinical value and demonstrate net benefit to patients.” He said many of Midjourney’s “claims about resolution are clearly theoretical” and that suggestions it could be an “MRI equivalent are completely unsupported.”

Can a company responsibly imply MRI-like usefulness before proving MRI-like clinical value?

Here is the cleaner comparison, based on the source material:

This is not a semantic dispute. If the Midjourney body scanner is mainly a fast body composition tool at launch, say that. If it is a future diagnostic platform, prove the future one clinical claim at a time.

Patients should not confuse image-generation brilliance with diagnostic trust

Midjourney earned its reputation by making synthetic images online. That is not a trivial achievement. It also does not transfer automatically to medical credibility.

In image generation, a flawed output can be funny, frustrating, or commercially inconvenient. In medical imaging, a flawed output can trigger false reassurance, panic, unnecessary follow-up, delayed care, or missed disease. The source does not say Midjourney’s scanner has caused any of those outcomes. The point is narrower and more important: those are the stakes health imaging must be designed to avoid.

What does Midjourney need before users should trust a scan as health-relevant?

At minimum, credible medical imaging claims need public evidence on sensitivity, specificity, reproducibility, real-world usefulness, and performance across bodies. The Verge reports that experts were not dismissive of the concept outright. Several found it plausible or exciting. But they kept returning to the same demand: proof.

Matthew Davenport, a professor of radiology at the University of Michigan Medical School, told The Verge that Midjourney’s published images were “interesting” and that he could see a market for body imaging. His larger verdict was blunt: the company’s “claims are wildly unsubstantiated,” perhaps “the most grandiose” he has seen.

That should be the headline inside Midjourney’s product meetings.

Clinicians know the vat is easier than validation

The water tank is visually dramatic, but it may not be the hardest part. Clinical validation is.

Controlled scans of phantoms can help establish whether structures separate cleanly under controlled conditions. They do not prove that a scanner works across ages, body sizes, implants, tissue variation, motion, uncertain findings, or messy real-world settings. They also do not prove that users benefit from frequent imaging.

Scott Reeder, a professor of radiology at University of Wisconsin School of Medicine and Public Health, called the concept “innovative,” but said it “is not a proven technology.” He also warned it “would be concerning if patients replaced proven screening technologies with this technology,” such as someone skipping a mammogram or colonoscopy because they believed a Midjourney scan had already checked them sufficiently.

How will Midjourney prevent wellness language from becoming diagnostic confidence in a customer’s mind?

That is not a minor UX issue. It is the center of the product.

William Morrison, a professor of radiology at Thomas Jefferson University, was harsher. He called the rollout “vibe-based” and said the images shown are “markedly limited compared to existing technology such as CT and MRI.” He also raised practical concerns about water purity, bubbles, dirt, hair, air, bone, and fat attenuation. Calloway told The Verge that bubbles are removed with “a large degasser located under the tank,” but that answers only one piece of a broader physics and operations problem.

XOOMAR analysis: Midjourney’s strongest near-term path is not to argue that skeptics lack imagination. It is to give them data they can test.

Outsiders can improve imaging, but guardrails decide who gets hurt

The best counterargument to all this skepticism is real. Medical imaging can be expensive, intimidating, slow, and unpleasant. MRI scans can require patients to lie still inside a narrow, noisy tube. CT involves ionizing radiation. A fast, comfortable, radiation-free scan that tracks changes over time could have value if the images are good enough and the clinical claims stay honest.

Should medicine welcome outsiders who are willing to attack old hardware problems from a new angle?

Yes. Midjourney deserves credit for aiming at something more consequential than another disposable AI feature. The concept of automated whole-body ultrasound is not ridiculous on its face. The Verge cites experts who called the idea plausible, exciting, or innovative.

But outsiders do not get a discount on evidence. They need stricter communication because they are entering a domain where users may overread vague claims. A spa setting makes that harder, not easier. It could reduce anxiety, but it could also make health screening feel casual in the wrong way.

For readers tracking adjacent XOOMAR coverage on technology and public risk, see our separate reports on Three Patients Test Cancer-Detecting Brain Implants and Starmer Targets TikTok With UK Under-16 Social Media Ban. Different sectors, same editorial standard: bold technology claims need scrutiny before scale.

The market signal is simple: publish the data before selling longer lives

Midjourney says its first spa will open in the “heart of San Francisco” in 2027. Its blog outlines planned generations, including a third-generation scanner in 2028, and a 2031 ambition of more than 50,000 scanners worldwide, enough, it says, to give monthly scans to a billion people.

That roadmap is breathtaking. It is also premature without transparent evidence.

Where should Midjourney go from here if it wants medical credibility rather than wellness buzz?

Publish peer-reviewed research. Name serious medical advisors and clinical partners. Release study designs, image quality metrics, failure modes, and comparison data against MRI, CT, standard ultrasound, and pathology-confirmed outcomes where applicable. Keep diagnostic language narrow until regulators and independent experts validate broader use cases.

Davenport’s warning deserves the final word because it cuts through the glamour:

“The interest in improving health through imaging is wonderful,” Davenport said. “The race to market with unproven claims that almost certainly will not prove true is ethically problematic.”

If Midjourney wants to scan bodies, surprise is not enough. In medicine, trust is built one validated result at a time.

Impact Analysis

• A misleading wellness scan could cause users to misunderstand their health risks.
• Clinicians and regulators will need evidence before MRI-like claims can be trusted.
• Midjourney’s move shows how AI companies may blur the line between consumer tech and medical devices.